
|Articles|July 1, 2003
Cancer Drug Reimbursement Facing Possible Reform
As Congress moves toward possible approval of a new prescription drug program for Medicare recipients later this summer, how payments for cancer drugs and therapeutic services are determined may well hang in the balance.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Auricular Acupuncture for Facial Rejuvenation: Results from a Large Real-World Clinical Series
2
Sun Pharma’s Cosibelimab-ipdl (UNLOXCYT) Enters US Market for Advanced CSCC
3
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
4
Lebrikizumab Enters Late-Stage Testing for Nummular Eczema
5


















